Recruiting

I-Reconstruction Psychotherapy for Anxiety Reduction

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to reduce anxiety levels in individuals through I-Reconstruction Psychotherapy, measuring changes in anxiety scores using the Beck Anxiety Inventory and Hospital Anxiety and Depression Scale, from the start of the therapy to 12 months later.

What is being tested

Experimental: Active "I-Reconstruction" Therapy

+ Standard Care (Treatment as Usual)

Drug
Who is being recruted

Anxiety Disorders+2

+ Behavior

+ Mental Disorders

From 18 to 55 Years
+3 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: March 2026
See protocol details

Summary

Principal SponsorInternational Association Psychosomatics And Health Therapy
Study ContactTetiana Pavlenko
Last updated: February 10, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 2, 2026

Actual date on which the first participant was enrolled.

Anxiety disorders are common mental health conditions that affect millions, impacting their life quality and social functioning. While Cognitive Behavioral Therapy (CBT) and medication are known to help, many patients still struggle with full recovery, highlighting the need for new therapeutic approaches. This study focuses on the I-Reconstruction psychotherapy method, a promising new approach that targets the root causes of anxiety. The method centers around desire, possession, and satisfaction, viewing them as fundamental elements of personality that shape our interactions with the world. This research aims to understand how this method can reduce anxiety levels in individuals with anxiety disorders, potentially filling the current treatment gap. This study is a randomized controlled trial involving three parallel groups, two experimental and one control. The participation duration is approximately 17 months, including an initial screening and assessment phase, a course of therapy sessions, and a series of delayed measurements at 3, 6, and 12 months after the intervention. Participants will be recruited online through the official pages of the NGO 'International Association of Psychosomatics and Health Therapy'. The primary outcomes measured include changes in anxiety levels using the Beck Anxiety Inventory (BAI) and the Hospital Anxiety and Depression Scale - Anxiety (HADS-A) subscale scores from baseline to 12 months after therapy. Additionally, changes in the total score according to the 'I - Reconstruction' diagnosis of preverbal dysregulation (DPD) method will also be evaluated.

Official TitleGroup Therapy Using the I-Reconstruction Psychotherapy Method for Reducing Anxiety Levels: a Randomized Controlled Trial
Principal SponsorInternational Association Psychosomatics And Health Therapy
Study ContactTetiana Pavlenko
Last updated: February 10, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

36 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 55 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Anxiety DisordersBehaviorMental DisordersBehavioral SymptomsDepression

Criteria

2 inclusion criteria required to participate
Significant level of preverbal trauma according to the 'Diagnostics of Preverbal Dysregulation' (DPD, T. Pavlenko) questionnaire: total score ≥ 16.

Willingness to comply with the study protocol and the online therapy format.

1 exclusion criteria prevent from participating
Use of any psychotropic medications within the last 30 days (antidepressants, tranquilizers, neuroleptics, mood stabilizers).

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

3 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Participants randomized to the experimental group received the active psychotherapeutic intervention "l-Reconstruction." This group consisted of adults with clinically significant anxiety who met all inclusion criteria of the study. Participants attended ten weekly online group therapy sessions led by a certified "l-Reconstruction" therapist. The group format was designed to facilitate therapeutic change through guided interpersonal interaction, normalization of experiences, and reflection within a structured therapeutic framework. All participants in the experimental group completed baseline, post-intervention, and follow-up assessments to evaluate changes in anxiety and related psychological outcomes.

Group II

Experimental
Participants randomized to the experimental group received the active psychotherapeutic intervention "l-Reconstruction." This group consisted of adults with clinically significant anxiety who met all inclusion criteria of the study. Participants attended ten weekly online group therapy sessions led by a certified "l-Reconstruction" therapist. The group format was designed to facilitate therapeutic change through guided interpersonal interaction, normalization of experiences, and reflection within a structured therapeutic framework. All participants in the experimental group completed baseline, post-intervention, and follow-up assessments to evaluate changes in anxiety and related psychological outcomes.

Group III

Standard Care (Treatment as Usual) Participants randomized to the control group received no therapeutic intervention during the study period. They continued with their usual daily activities and were not restricted from seeking any form of support or care outside the study. The control group participated only in scheduled psychological assessments at baseline, post-intervention, and follow-up time points, allowing for comparison of outcome trajectories between the intervention and non-intervention conditions.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

International Association of Psychosomatics and Body Therapy

Kyiv, UkraineOpen International Association of Psychosomatics and Body Therapy in Google Maps
Recruiting
One Study Center